المؤلفون: Žunić Tatjana, Ponjavić Milojka

المصدر: Arhiv za farmaciju, Vol 70, Iss 4, Pp 198-223 (2020)

مصطلحات موضوعية: type 2 diabetes, cardiovascular protection, sodium-glucose co-transporter 2 (sglt2) inhibitors, glucagon-like peptide-1 receptor agonists (glp-1 agonists), cardiovascular outcome trials, Pharmacy and materia medica, RS1-441

وصف الملف: electronic resource

العلاقة: https://scindeks-clanci.ceon.rs/data/pdf/0004-1963/2020/0004-19632004198Q.pdfTest; https://doaj.org/toc/0004-1963Test; https://doaj.org/toc/2217-8767Test

الوصول الحر: https://doaj.org/article/8492a9c7c8f8421992593020bae0f9b7Test

المؤلفون: Žunić, Tatjana, Bjeletić, Jasminka, Tadić, Ivana, Odalović, Marina, Lakić, Dragana, Brkić, Jovana

المصدر: Zbornik sažetaka

العلاقة: https://farfar.pharmacy.bg.ac.rs/handle/123456789/4223Test; https://hdl.handle.net/21.15107/rcub_farfar_4223Test

الإتاحة: https://farfar.pharmacy.bg.ac.rs/handle/123456789/4223Test
https://hdl.handle.net/21.15107/rcub_farfar_4223Test

المؤلفون: Žunić, Tatjana, Bjeletić, Jasminka, Tadić, Ivana, Odalović, Marina, Lakić, Dragana, Brkić, Jovana

المصدر: Zbornik sažetaka

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______4877::be1f8cc6a0039330a9b6baa11587197fTest
https://hdl.handle.net/21.15107/rcub_farfar_4223Test

المؤلفون: Žunić, Tatjana¹

المصدر: Medical Gazette / Medicinski Glasnik. 2012, Vol. 17 Issue 46S, p171-171. 1p.